Why the study?
Does current hormone replacement therapy use improve glycated haemoglobin (HbA1C) levels in non-diabetic postmenopausal women?
Does current hormone replacement therapy use improve glycated haemoglobin (HbA1C) levels in non-diabetic postmenopausal women?
Current use of hormone replacement therapy in postmenopausal women is associated with lower HbA1C levels, suggesting it does not impair glucose tolerance.
No takes yet. Share an insight, caveat, or question.
Current HRT use was associated with lower HbA1C; hypothesis-generating and should not yet change practice.
Sargeant et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: